BSE filing, NSE: SAGILITY. Summary written from the filing by ALFA Finder's alert engine.
Sagility Ltd: key numbers
- Share price
- ₹45.29
- Market cap
- ₹21,202 Cr
- Revenue (annual)
- ₹7,193 Cr
- Net profit (annual)
- ₹924.8 Cr
- P/E (TTM)
- 20.7×Sector 52.0×
- Promoter holding
- 50.95%+0.00% QoQ
- FII holding
- 10.38%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sagility Ltd
All →Sagility Dividend
Sagility Limited declared an interim dividend of ₹0.15 per equity share for the financial year 2026-27. The record date is set for October 30, 2026.
Sagility Results Update
Sagility Ltd reported Q2 FY27 revenue of ₹2,032.1 Crore, up 22.5% YoY. The company also declared an interim dividend of ₹0.15 per share.
Sagility Investor Presentation: Key Takeaways
Sagility reported strong Q2 FY27 performance with 22.5% YoY revenue growth and 26.3% adjusted EBITDA margin. Performance driven by organic expansion in payer segments and strategic acquisition of Chirok Health.
Sagility Q2 FY27 Results: Net Profit ₹284.2 Cr, Up 13.3% YoY
Sagility Ltd reported revenue from operations of ₹2,032 Cr (+22.5% YoY) and net profit of ₹284.2 Cr (+13.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹284.2 Cr · +13.3% YoY
Sagility Acquisition Worth ₹304.1 Cr
Sagility's US subsidiary is acquiring Chirok Health LLC for up to US$ 32.35 million. This 100% stake acquisition strengthens Sagility's provider segment capabilities.
- Value
- ₹304.1 Cr
Sagility Board Meeting Date
Sagility Ltd disclosed its Board is scheduled for 22 Oct 2026 to consider Q1/H1 FY27 results and any interim dividend. No decision has been taken yet.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date